UK markets open in 32 minutes

Xspray Pharma AB (publ) (XSPRAS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
0.00000.0000 (+0.20%)
At close: 08:04AM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-212,581
-179,667
-131,670
-96,698
-52,410
-
Depreciation & amortisation
11,895
9,194
9,533
8,870
7,689
-
Change in working capital
-8,212
-31,581
-3,575
4,375
-1,315
-
Inventory
-35,050
-35,229
0
-
-
-
Other working capital
-258,681
-257,378
-238,465
-147,571
-141,347
-
Other non-cash items
-
-
-
-
-1,262
-1,892
Net cash provided by operating activities
-213,051
-203,275
-110,179
-51,607
-47,792
-
Cash flows from investing activities
Investments in property, plant and equipment
-45,630
-54,103
-128,286
-95,964
-93,555
-
Other investing activities
-
-11,773
-7,059
-9,854
-3,656
-
Net cash used for investing activities
-56,375
-65,876
-135,345
-105,818
-96,828
-
Net change in cash
44,930
46,443
-151,715
-53,717
115,726
-
Cash at beginning of period
59,395
120,166
271,881
325,598
209,872
-
Cash at end of period
104,325
166,303
120,166
271,881
325,598
-
Free cash flow
Operating cash flow
-213,051
-203,275
-110,179
-51,607
-47,792
-
Capital expenditure
-45,630
-54,103
-128,286
-95,964
-93,555
-
Free cash flow
-258,681
-257,378
-238,465
-147,571
-141,347
-